scholarly journals Non-dipping pattern of nocturnal blood pressure as a risk factor for macular ischemia in branch retinal vein occlusion

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Gwang Myeong Noh ◽  
Haeyoung Lee ◽  
Hyun Duck Kwak ◽  
Hyun Wong Kim ◽  
Sang Joon Lee

AbstractBranch retinal vein occlusion (BRVO) is ocular vascular disease affecting approximately 14 million people worldwide, and is closely associated with high blood pressure (BP). Although macular ischemia is a critical factor in the visual prognosis of BRVO, the relationship between macular ischemia and different patterns of nocturnal BP is unknown. Here, we investigated whether a dipping pattern of nocturnal BP is associated with the development of macular ischemia in patients with BRVO. A total of 273 patients were reviewed; of these, 86 (86 eyes) patients were included. All recruited patients had a macular thickness map by optical coherence tomography and underwent 24-h ambulatory BP monitoring. According to their dipping patterns, the participants were divided into dipper and non-dipper groups. The non-dipper group had worse visual outcomes at the initial and 6-month visits (P = 0.014 and P = 0.003, respectively). Five of 32 eyes (15.6%) in the dipper group and 32 of 54 (59.3%) in the non-dipper group had macular ischemia. In a multivariate analysis, the night-to-day systolic BP ratio was associated with the degree of macular ischemia (β = − 0.313, P = 0.004). Thus, a non-dipping pattern may be a risk factor for macular ischemia in patients with BRVO.

1994 ◽  
Vol 117 (2) ◽  
pp. 211-213 ◽  
Author(s):  
Giovanni Staurenghi ◽  
Christina Lonati ◽  
Monica Aschero ◽  
Nicola Orzalesi

2003 ◽  
Vol 13 (7) ◽  
pp. 648-652 ◽  
Author(s):  
J. Swart ◽  
J.W. Reichert-Thoen ◽  
M.S. Suttorp-Schulten ◽  
G.H. Van Rens ◽  
B.C. Polak

2017 ◽  
Vol 8 (1) ◽  
pp. 271-278 ◽  
Author(s):  
Thomas Bertelmann ◽  
Hans Ulrich Frank ◽  
Hendrik Ansgar Fuchs ◽  
Nicolas Feltgen

Purpose: To report a case with ischemic macular edema (ME) due to an acute branch retinal vein occlusion (BRVO) which was treated with repeated intravitreal anti-VEGF injections. Methods: Retrospective case presentation. Results: A 66-year-old female patient was treated with repeated intravitreal anti-VEGF injections due to ischemic ME following an acute BRVO. Over a period of 2.5 years best corrected visual acuity increased from 0.06 to 0.6 (decimal notation) accompanied by a reduction in central retinal thickness from 546 to 292 µm. Overall 17 anti-VEGF injections were administered to treat repeated recurrence of ME. Macular ischemia did not worsen during this profound intravitreal anti-VEGF therapy. Conclusion: Intravitreal anti-VEGF therapy can be a beneficial treatment strategy even in ischemic ME following an acute BRVO.


2016 ◽  
Vol 34 (Supplement 1) ◽  
pp. e142
Author(s):  
Jeong-Sook Seo ◽  
Ho-Cheol Shin ◽  
Han-Young Jin ◽  
Jae-Sik Jang ◽  
Tae-Hyun Yang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document